Maria Fragiadaki

This study shows EPAS1 reduces atherosclerosis at disturbed flow sites by promoting endothelial fatty acid uptake and metabolism, which is suppressed in obesity through triglyceride-PHD3 pathway.

This study identifies ANKHD1 as a driver of ADPKD by promoting proliferation and fibrosis, showing its inhibition could be therapeutically beneficial.

This study investigates JAK2's role in cystogenesis using a murine model, finding that JAK2 inhibition reduces cystic growth in vitro.